CD40L disruption enhances Abeta vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation.

Source:http://linkedlifedata.com/resource/pubmed/id/18055209

Download in:

View as

General Info

PMID
18055209